ErbB2/Her2 Antibody (rERBB2/6637)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-23581
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Mouse IgG2b Kappa Clone # rERBB2/6637
Concentration
0.2 mg/ml
Product Specifications
Immunogen
Recombinant protein encoding the extracellular domain of human ErbB2/Her2
Localization
Cell Surface
Specificity
This monoclonal antibody is specific and shows minimal cross-reaction with other members of the EGFR-family.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Description
Store at 2 to 8C. Non-hazardous. No MSDS required.
Applications for ErbB2/Her2 Antibody (rERBB2/6637)
Application
Recommended Usage
Immunohistochemistry-Paraffin
1-2ug/ml
Application Notes
Immunohistochemistry-Paraffin: 1-2ug/ml for 30 minutes at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95C followed by cooling at RT for 20 minutes. Optimal dilution for a specific application should be determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
10mM PBS with 0.05% BSA
Preservative
0.05% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C.
Background: ErbB2/Her2
Long Name
Receptor Tyrosine Protein Kinase ErbB2
Alternate Names
CD340, HER2, Neu Oncogene, NGL, TKR1
Gene Symbol
ERBB2
Additional ErbB2/Her2 Products
Product Documents for ErbB2/Her2 Antibody (rERBB2/6637)
Product Specific Notices for ErbB2/Her2 Antibody (rERBB2/6637)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...